Experimental studies on the spread of cancer, with special reference to fibrinolytic agents and anticoagulants.
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001728:Dicumarol / Q000627:therapeutic use; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004428:Ear Neoplasms / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D004727:Endothelium / Q000473:pathology; D005176:Factor XIII / Q000037:antagonists & inhibitors; D005341:Fibrinolysin / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D007457:Iodine Radioisotopes; D008175:Lung Neoplasms / Q000188:drug therapy; D008207:Lymphatic Metastasis; D051379:Mice; D008833:Microcirculation / Q000187:drug effects; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000473:pathology; D009360:Neoplastic Cells, Circulating; D010973:Platelet Adhesiveness / Q000187:drug effects; D011817:Rabbits; D013927:Thrombosis / Q000150:complications; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D000970:Antineoplastic Agents; D005343:Fibrinolytic Agents; D007457:Iodine Radioisotopes; D014859:Warfarin; D001728:Dicumarol; D006493:Heparin; D005176:Factor XIII; D005341:Fibrinolysin